A Comparative Analysis of Factors Influencing Two Outbreaks of Middle Eastern Respiratory Syndrome (MERS) in Saudi Arabia and South Korea.
Animals
Communicable Disease Control
/ methods
Coronavirus Infections
/ epidemiology
Disease Outbreaks
/ prevention & control
Health Knowledge, Attitudes, Practice
Humans
Middle East Respiratory Syndrome Coronavirus
/ physiology
Republic of Korea
/ epidemiology
Saudi Arabia
/ epidemiology
Zoonoses
/ transmission
Middle East
Middle East Respiratory Syndrome (MERS), zoonosis
Saudi Arabia
South Korea
coronavirus
Journal
Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722
Informations de publication
Date de publication:
03 12 2019
03 12 2019
Historique:
received:
06
11
2019
revised:
27
11
2019
accepted:
02
12
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
20
9
2020
Statut:
epublish
Résumé
In 2012, an emerging viral infection was identified in Saudi Arabia that subsequently spread to 27 additional countries globally, though cases may have occurred elsewhere. The virus was ultimately named Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), and has been endemic in Saudi Arabia since 2012. As of September 2019, 2468 laboratory-confirmed cases with 851 associated deaths have occurred with a case fatality rate of 34.4%, according to the World Health Organization. An imported case of MERS occurred in South Korea in 2015, stimulating a multi-month outbreak. Several distinguishing factors emerge upon epidemiological and sociological analysis of the two outbreaks including public awareness of the MERS outbreak, and transmission and synchronization of governing healthcare bodies. South Korea implemented a stringent healthcare model that protected patients and healthcare workers alike through prevention and high levels of public information. In addition, many details about MERS-CoV virology, transmission, pathological progression, and even the reservoir, remain unknown. This paper aims to delineate the key differences between the two regional outbreaks from both a healthcare and personal perspective including differing hospital practices, information and public knowledge, cultural practices, and reservoirs, among others. Further details about differing emergency outbreak responses, public information, and guidelines put in place to protect hospitals and citizens could improve the outcome of future MERS outbreaks.
Identifiants
pubmed: 31817037
pii: v11121119
doi: 10.3390/v11121119
pmc: PMC6950189
pii:
doi:
Types de publication
Comparative Study
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : CIHR
ID : 950-231498
Pays : Canada
Déclaration de conflit d'intérêts
The authors declare no conflicts of interest.
Références
Eur Respir J. 2013 Jul;42(1):198-210
pubmed: 23100504
J Virol. 2015 Nov;89(21):10970-81
pubmed: 26311885
Epidemiol Health. 2015 Jul 21;37:e2015033
pubmed: 26212508
Osong Public Health Res Perspect. 2015 Aug;6(4):269-78
pubmed: 26473095
Lancet. 2016 Sep 3;388(10048):994-1001
pubmed: 27402381
Infect Chemother. 2015 Sep;47(3):212-22
pubmed: 26483999
Int J Qual Health Care. 2005 Aug;17(4):331-46
pubmed: 15883128
Transbound Emerg Dis. 2017 Apr;64(2):344-353
pubmed: 26256102
Virol J. 2013 Dec 23;10:359
pubmed: 24364985
Vector Borne Zoonotic Dis. 2019 Mar;19(3):174-192
pubmed: 30676269
PLoS Curr. 2014 Dec 18;6:null
pubmed: 25685622
Sci Rep. 2016 Oct 24;6:35839
pubmed: 27775012
Clin Microbiol Rev. 2015 Apr;28(2):465-522
pubmed: 25810418
Emerg Infect Dis. 2004 Feb;10(2):173-5
pubmed: 15040346
J Infect Public Health. 2017 Sep - Oct;10(5):534-540
pubmed: 28185821
Epidemiol Infect. 2005 Apr;133(2):273-7
pubmed: 15816152
BMC Public Health. 2018 May 2;18(1):574
pubmed: 29716568
Virol J. 2015 Dec 22;12:222
pubmed: 26695637
Protein Cell. 2013 Dec;4(12):951-61
pubmed: 24318862
Indian J Radiol Imaging. 2017 Jul-Sep;27(3):342-349
pubmed: 29089687
N Engl J Med. 2013 Jun 27;368(26):2487-94
pubmed: 23718156
N Engl J Med. 2012 Nov 8;367(19):1814-20
pubmed: 23075143
J Hosp Infect. 2017 Feb;95(2):207-213
pubmed: 28153558
J Pathol. 2015 Jan;235(2):175-84
pubmed: 25294366
Emerg Infect Dis. 2006 Dec;12(12):1834-40
pubmed: 17326933
mBio. 2014 Feb 18;5(1):null
pubmed: 24549846
Saudi J Biol Sci. 2018 Nov;25(7):1402-1405
pubmed: 30505188
Health Policy. 2016 Jun;120(6):621-9
pubmed: 26831040
Emerg Infect Dis. 2017 Jun;23(6):898-905
pubmed: 28516865
J Korean Med Sci. 2017 May;32(5):744-749
pubmed: 28378546
Emerg Infect Dis. 2013 Nov;19(11):1819-23
pubmed: 24206838
Front Biosci (Landmark Ed). 2018 Jun 1;23:1754-1779
pubmed: 29772527
J Environ Public Health. 2018 Jun 28;2018:2710185
pubmed: 30050581
Clin Infect Dis. 2016 Dec 10;64(5):551-557
pubmed: 27940937
Viruses. 2018 Nov 30;10(12):
pubmed: 30513619
PLoS One. 2018 Sep 5;13(9):e0203489
pubmed: 30183777
Expert Opin Ther Targets. 2017 Feb;21(2):131-143
pubmed: 27936982
J Infect Public Health. 2016 May-Jun;9(3):216-9
pubmed: 27106390
Korean J Intern Med. 2018 Mar;33(2):233-246
pubmed: 29506344
Sci Rep. 2019 May 14;9(1):7385
pubmed: 31089148
J Family Med Prim Care. 2018 Jul-Aug;7(4):658-663
pubmed: 30234034
Epidemiol Infect. 2019 Jan;147:e84
pubmed: 30869000
Viruses. 2019 Jan 14;11(1):
pubmed: 30646569
J Virol. 2013 Dec;87(23):12552-61
pubmed: 24027332
Nat Rev Microbiol. 2016 Aug;14(8):523-34
pubmed: 27344959
Antiviral Res. 2013 Oct;100(1):286-95
pubmed: 24012996
Ann Saudi Med. 2008 Jul-Aug;28(4):243-50
pubmed: 18596400
Z Gesundh Wiss. 2018;26(6):607-612
pubmed: 30533343
BMC Infect Dis. 2012 Dec 20;12:365
pubmed: 23256846
Front Med. 2017 Sep;11(3):365-377
pubmed: 28500431
Ann Transl Med. 2017 Jul;5(14):283
pubmed: 28828358
Infect Chemother. 2015 Dec;47(4):278-302
pubmed: 26788414
Science. 2016 Jan 1;351(6268):77-81
pubmed: 26678878
Methods Mol Biol. 2015;1282:1-23
pubmed: 25720466
Emerg Infect Dis. 2017 Feb;23(2):232-240
pubmed: 27901465
Eur J Clin Microbiol Infect Dis. 2018 Feb;37(2):363-369
pubmed: 29214503
J Virol. 2010 Jan;84(2):1198-205
pubmed: 19864379